Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version.
    Difference
    0.0%
    Check dated 2026-07-04T12:53:48.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the prior Revision: v3.6.0, indicating an update to the page’s revision history.
    Difference
    0.0%
    Check dated 2026-06-27T06:26:45.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    New user-guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a header for Intervention/Treatment appears in the study details. A recruitment status note 'No longer looking for participants' was added and the page revision is labeled v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T00:16:35.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a minor update or correction to the page’s documentation or layout rather than a change to the study details. No substantive study information appears to have been modified.
    Difference
    0.0%
    Check dated 2026-06-05T21:31:37.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new page revision tag 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' tag was removed, signaling a version update of the page without altering the study details.
    Difference
    0.0%
    Check dated 2026-05-15T14:20:18.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The Taiwan site entry with postal code 333 was updated to Taoyuan City, Taiwan, 333. The previous Taoyuan, Taiwan, 333 entry was removed and replaced with the Taoyuan City variant to reflect the corrected city designation.
    Difference
    0.0%
    Check dated 2026-05-08T11:55:28.000Z thumbnail image

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.